Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VIVO Cannabis Inc. V.PDA


Primary Symbol: VVCIF

Healthcare Drug Manufacturers - Specialty & Generic
VIVO Cannabis Inc is a Canada-based company. It is involved in the production and sale of medical and recreational cannabis and the provision of cannabis-related medical information and services in Canada. The company's operating segment includes Cannabis, Patient Clinics, and Corporate. It generates maximum revenue from the Cannabis segment. The company has a presence across three geographical locations - Canada, Germany, and Australia.


OTCQB:VVCIF - Post by User

VIVO Cannabis Inc. > Canaccord Reaffirms Target on Vivo of $1.80 :)
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(775)
•••
Post by 1hot-techwomanon Jul 26, 2019 7:46am
162 Views
Post# 29962844

Canaccord Reaffirms Target on Vivo of $1.80 :)

Canaccord Reaffirms Target on Vivo of $1.80 :)June 5, 2019 Canadian Market, Healthcare, Top Market News 0 Comments Canaccord Genuity Reaffirms Their Buy Rating on VIVO Cannabis Inc (VIVO) By Jason Carr In a new note to investors today, an analyst has provided a rating update for VIVO Cannabis Inc (VIVO Research Report). The company received a Buy rating from Canaccord Genuitys analyst Kimberly Hedlin, with a C$1.80 price target. According to TipRanks.com, Hedlin is ranked #718 out of 5173 analysts. VIVO Cannabis Inc has an analyst consensus of Moderate Buy, with a price target consensus of C$1.80, a 185.7% upside from current levels. In a report issued on May 30, PI Financial also maintained a Buy rating on the stock with a C$1.80 price target.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities